FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3210725338> ?p ?o ?g. }

• W3210725338 abstract "Evidence is needed to guide the inclusion of broader groups of people living with HIV (PLHIV) in differentiated service delivery (DSD) programmes. We assessed treatment outcomes among PLHIV on second-line regimens in a community antiretroviral therapy (ART) delivery programme, compared to those who remained at clinics.Using data from 61 public clinics, we did a retrospective cohort study among PLHIV receiving second-line ART following rollout of the Centralized Chronic Medicines Dispensing and Distribution (CCMDD) programme in KwaZulu-Natal, South Africa. We included PLHIV from the timepoint when they were first eligible, though not necessarily referred, for community ART within CCMDD and followed them for 18 months. We used multivariable logistic regression to compare 12-month attrition and viraemia between clients referred for community ART and those remaining in clinic care.Among 209,744 PLHIV aged ≥ 18 years who collected ART between October 2016 and December 2018, 7511 (3.6%) received second-line ART. Of these, 2575 (34.3%) were eligible for community ART. The median age was 39.0 years (interquartile range 34.0-45.0) and 1670 (64.9%) were women. Five hundred and eighty-four (22.7%) were referred for community ART within 6 months of meeting eligibility criteria. Overall, 4.5% [95% confidence interval (CI) 3.0-6.6%] in community ART and 4.4% (95% CI 3.5-5.4%) in clinic care experienced attrition at 12 months post eligibility for community ART. Two thousand one hundred and thirty-eight (83.0%) had a viral load recorded 6-18 months after becoming eligible, and of these, 10.3% (95% CI 7.7-13.3%) in community ART and 11.3% (95% CI 9.8-12.9%) in clinic care had viraemia > 200 copies/ml. In separate regressions adjusted for age, gender, district, time on second-line ART, nucleoside reverse transcriptase inhibitor backbone and year of eligibility, no differences in the odds of attrition [adjusted odds ratio (aOR) 1.02, 95% CI 0.71-1.47] or viraemia (aOR 0.91, 95% CI 0.64-1.29) were observed between those in community ART and those remaining in clinic care.We found good outcomes among PLHIV who were stable on second-line regimens and referred for community ART. Efforts to expand DSD access among this group should be prioritized." @default.
• W3210725338 created "2021-11-08" @default.
• W3210725338 creator A5002837207 @default.
• W3210725338 creator A5006424587 @default.
• W3210725338 creator A5007528258 @default.
• W3210725338 creator A5008357689 @default.
• W3210725338 creator A5008553483 @default.
• W3210725338 creator A5021011348 @default.
• W3210725338 creator A5028693464 @default.
• W3210725338 creator A5053768627 @default.
• W3210725338 creator A5081748396 @default.
• W3210725338 creator A5088561200 @default.
• W3210725338 date "2021-10-01" @default.
• W3210725338 modified "2023-09-24" @default.
• W3210725338 title "Differentiated service delivery for people using second‐line antiretroviral therapy: clinical outcomes from a retrospective cohort study in KwaZulu‐Natal, South Africa" @default.
• W3210725338 cites W1971077001 @default.
• W3210725338 cites W1987792428 @default.
• W3210725338 cites W2137413238 @default.
• W3210725338 cites W2146396572 @default.
• W3210725338 cites W2558188285 @default.
• W3210725338 cites W2734504115 @default.
• W3210725338 cites W2761519329 @default.
• W3210725338 cites W2762323838 @default.
• W3210725338 cites W2899516169 @default.
• W3210725338 cites W2949538910 @default.
• W3210725338 cites W3015896172 @default.
• W3210725338 cites W3020227720 @default.
• W3210725338 cites W3024705890 @default.
• W3210725338 cites W3028740384 @default.
• W3210725338 cites W3087723169 @default.
• W3210725338 cites W3162541758 @default.
• W3210725338 doi "https://doi.org/10.1002/jia2.25802" @default.
• W3210725338 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8554220" @default.
• W3210725338 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34713545" @default.
• W3210725338 hasPublicationYear "2021" @default.
• W3210725338 type Work @default.
• W3210725338 sameAs 3210725338 @default.
• W3210725338 citedByCount "5" @default.
• W3210725338 countsByYear W32107253382021 @default.
• W3210725338 countsByYear W32107253382022 @default.
• W3210725338 countsByYear W32107253382023 @default.
• W3210725338 crossrefType "journal-article" @default.
• W3210725338 hasAuthorship W3210725338A5002837207 @default.
• W3210725338 hasAuthorship W3210725338A5006424587 @default.
• W3210725338 hasAuthorship W3210725338A5007528258 @default.
• W3210725338 hasAuthorship W3210725338A5008357689 @default.
• W3210725338 hasAuthorship W3210725338A5008553483 @default.
• W3210725338 hasAuthorship W3210725338A5021011348 @default.
• W3210725338 hasAuthorship W3210725338A5028693464 @default.
• W3210725338 hasAuthorship W3210725338A5053768627 @default.
• W3210725338 hasAuthorship W3210725338A5081748396 @default.
• W3210725338 hasAuthorship W3210725338A5088561200 @default.
• W3210725338 hasBestOaLocation W32107253381 @default.
• W3210725338 hasConcept C119060515 @default.
• W3210725338 hasConcept C126322002 @default.
• W3210725338 hasConcept C136264566 @default.
• W3210725338 hasConcept C142462285 @default.
• W3210725338 hasConcept C144024400 @default.
• W3210725338 hasConcept C149923435 @default.
• W3210725338 hasConcept C151956035 @default.
• W3210725338 hasConcept C162324750 @default.
• W3210725338 hasConcept C167135981 @default.
• W3210725338 hasConcept C187212893 @default.
• W3210725338 hasConcept C199343813 @default.
• W3210725338 hasConcept C2777215511 @default.
• W3210725338 hasConcept C2780378061 @default.
• W3210725338 hasConcept C2780553607 @default.
• W3210725338 hasConcept C2993143319 @default.
• W3210725338 hasConcept C3013748606 @default.
• W3210725338 hasConcept C44249647 @default.
• W3210725338 hasConcept C512399662 @default.
• W3210725338 hasConcept C68595000 @default.
• W3210725338 hasConcept C71924100 @default.
• W3210725338 hasConcept C72563966 @default.
• W3210725338 hasConceptScore W3210725338C119060515 @default.
• W3210725338 hasConceptScore W3210725338C126322002 @default.
• W3210725338 hasConceptScore W3210725338C136264566 @default.
• W3210725338 hasConceptScore W3210725338C142462285 @default.
• W3210725338 hasConceptScore W3210725338C144024400 @default.
• W3210725338 hasConceptScore W3210725338C149923435 @default.
• W3210725338 hasConceptScore W3210725338C151956035 @default.
• W3210725338 hasConceptScore W3210725338C162324750 @default.
• W3210725338 hasConceptScore W3210725338C167135981 @default.
• W3210725338 hasConceptScore W3210725338C187212893 @default.
• W3210725338 hasConceptScore W3210725338C199343813 @default.
• W3210725338 hasConceptScore W3210725338C2777215511 @default.
• W3210725338 hasConceptScore W3210725338C2780378061 @default.
• W3210725338 hasConceptScore W3210725338C2780553607 @default.
• W3210725338 hasConceptScore W3210725338C2993143319 @default.
• W3210725338 hasConceptScore W3210725338C3013748606 @default.
• W3210725338 hasConceptScore W3210725338C44249647 @default.
• W3210725338 hasConceptScore W3210725338C512399662 @default.
• W3210725338 hasConceptScore W3210725338C68595000 @default.
• W3210725338 hasConceptScore W3210725338C71924100 @default.
• W3210725338 hasConceptScore W3210725338C72563966 @default.
• W3210725338 hasFunder F4320311904 @default.
• W3210725338 hasIssue "S6" @default.
• W3210725338 hasLocation W32107253381 @default.
• W3210725338 hasLocation W32107253382 @default.
• W3210725338 hasLocation W32107253383 @default.

• next